|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date27 May 1983 |
|
MechanismErgosterol biosynthesis inhibitors |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismBcr-Abl inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 3 一项验证吸入用盐酸氨溴索溶液改善下呼吸道感染疾病黏痰症状的多中心、随机、双盲、安慰剂平行对照临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled clinical study to verify the efficacy of inhaled ambroxol hydrochloride solution in improving the sputum symptoms of lower respiratory tract infections
验证吸入用盐酸氨溴索溶液改善下呼吸道感染疾病黏痰症状的有效性和安全性。
[Translation] To verify the effectiveness and safety of inhaled ambroxol hydrochloride solution in improving the symptoms of sticky sputum in lower respiratory tract infections.
硫酸美迪替尼片在初治慢性髓系白血病慢性期受试者中单次给药剂量递增Ⅰ期临床试验
[Translation] Phase I clinical trial of single-dose escalation of Meditinib sulfate tablets in subjects with chronic phase chronic myeloid leukemia who were previously untreated
本研究的主要目的为研究初治慢性髓系白血病慢性期受试者单次口服硫酸美迪替尼片的耐受性和安全性;次要目的为考察初治慢性髓系白血病慢性期受试者单次口服硫酸美迪替尼片的人体药代动力学特征。
[Translation] The main purpose of this study is to investigate the tolerability and safety of a single oral administration of Meditinib sulfate tablets in subjects with newly diagnosed chronic myeloid leukemia in the chronic phase; the secondary purpose is to investigate the human pharmacokinetic characteristics of a single oral administration of Meditinib sulfate tablets in subjects with newly diagnosed chronic myeloid leukemia in the chronic phase.
/ Active, not recruitingPhase 2 评价硝酸芬替康唑栓的有效性和安全性的多中心、随机、盲法、阳性药物平行对照II期临床试验
[Translation] A multicenter, randomized, blinded, positive drug parallel controlled phase II clinical trial to evaluate the efficacy and safety of fenticonazole nitrate suppositories
评价硝酸芬替康唑栓治疗外阴阴道念珠菌病的有效性和安全性,探索硝酸芬替康唑栓治疗外阴阴道念珠菌病的临床使用剂量。
[Translation] To evaluate the efficacy and safety of fenticonazole nitrate suppositories in the treatment of vulvovaginal candidiasis and to explore the clinical dosage of fenticonazole nitrate suppositories in the treatment of vulvovaginal candidiasis.
100 Clinical Results associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
0 Patents (Medical) associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
100 Deals associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
100 Translational Medicine associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.